Mount Sinai Researchers Help Create Largest Immune Cell Atlas of Bone Marrow in Multiple Myeloma Patients
On Jan. 9, 2026, scientists at the Icahn School of Medicine at Mount Sinai, in partnership with the Multiple Myeloma Research…
On Jan. 9, 2026, scientists at the Icahn School of Medicine at Mount Sinai, in partnership with the Multiple Myeloma Research…
On Nov. 17, 2025, Johnson & Johnson announced that it has entered into a definitive agreement to acquire…
On Oct. 17, 2025, Chinese biotech Hansoh Pharma said it had signed a license agreement worth up to…
On Aug. 6, 2025, Jazz Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Modeyso™ (dordaviprone)…
On Nov. 27, 2018, the Canadian Cancer Trials Group, a new clinical trial, opened across Canada. This was…
On Oct. 22, 2018, the National Cancer Institute (NC) awarded a $10.7 million five year grant to Abramson…
On Dec. 11, 2015, Genentech announced that it’s drug Alecensa (alectinib) was approved by the U.S. Food and…
On Nov. 19, 2003, a novel approach to treatment of solid cancers involved therapeutic agents that inhibit the…
Dec. 22, 1998, researchers from Barnes-Jewish Hospital in St. Louis announced using a revolutionary system that uses superconducting…
On Dec. 20, 1984, a team of scientists announced that a cDNA clone for human p53 cellular tumor…
In 1975, Caltech President David Baltimore, former Caltech faculty member and Salk Institute researcher Renato Delbucco, and Caltech…
In 1964, a new herpesvirus, Epstein-Barr virus (EBV), was discovered in cultured tumor cells derived from a Burkitt…
In 1939, Hugh G. Grady and Harold L. Stewart first identified the type II cell of the pulmonary…